Brief: Novavax Inc - Enters License Agreement With Pfizer - SEC Filing

Novavax

20/01/2026 12:24

Jan 20 (Reuters) - Novavax Inc NVAX.O:

NOVAVAX INC - ENTERS LICENSE AGREEMENT WITH PFIZER - SEC FILING

NOVAVAX INC - TO RECEIVE $30 MILLION UPFRONT PAYMENT IN Q1 2026 - SEC FILING

NOVAVAX INC - ELIGIBLE FOR UP TO $500 MILLION IN MILESTONE PAYMENTS - SEC FILING

NOVAVAX: PFIZER TO HAVE CONTROL OF MATTERS RELATING TO DEVELOPMENT, MANUFACTURE & COMMERCIALIZATION OF PRODUCTS THAT CONTAIN ADJUVANT

Source text: [ID:n0001104659-26-004785]

Further company coverage: NVAX.O

 (Reporting by Kunal Das)

 ((Kunal.Das2@thomsonreuters.com;))